|
|
氯硝柳胺的老药新用开发
|
Abstract:
根据药物氯硝柳胺在各国药典的收录情况，查阅该药物存在的经典文献；并了解老药新用的术语、好处、方法及经典。发现氯硝柳胺在癌症、糖尿病、帕金森及病毒等方面利用老药新用的最新研究状况，该药物存在着巨大的生产价值，值得药物生产企业大力关注。
The niclosamide are included in various Pharmacopoeia, the classic literature of the drug discovery are reviewed; the new terms, advantages, methods and classics of old drug for new use are reviewed. The research status of niclosamide in cancer, diabetes, Parkinson and virus is reviewed. The drug has a huge production value and deserves the vigorous attention of drug manufacturers.
| [1] | https://pubchem.ncbi.nlm.nih.gov/compound/niclosamide |
| [2] | 国家药典委员会. 中华人民共和国药典[M]. 第一部. 北京: 中国医药科技出版社, 2015: 248. |
| [3] | Cartwright, A.C. (2016) The British Pharmacopoeia, 1864 to 2014. Isis, Vol. 107. https://doi.org/10.1086/688369 |
| [4] | European Pharmacopoeia Commission (2019) European Pharmacopoeia. 10th Edition, European Directorate for Quality Medicines, Strasbourg, 68-97. |
| [5] | WHO (2020) The International Pharmacopoeia (Ph.Int.)-Radi Pharmareutirals.
https://digicollections.net/phint/2020/index.html#d/b.6.1.248 |
| [6] | Sail, V. and Hadden, M.K. (2012) Chapter Eighteen. Notch Pathway Modulators as Anticancer Chemotherapeutics. In: Annual Reports in Medicinal Chemistry, Vol. 47, Elsevier, Amsterdam, 267-280.
https://doi.org/10.1016/B978-0-12-396492-2.00018-7 |
| [7] | G？nnert, R. and Scluaufst？tter, E. (1958) A New Molluscicide: Molluscicide Bayer 73. Proceedings 6th International Congress for Tropical Medicine Malaria, Lisbon, Vol. 2, 197-202. |
| [8] | Schraufstaetter, E. and Goennert, R. (1959) Gastropoden-Bekaempfungsmittel. DE1024745, 1958; Gastropod Combating Composition. GB824345. |
| [9] | Schraufstatter, E. and Gonnert, R. (1963) Method of Combating Gastropods. US3079297. |
| [10] | Scluaufst？tter, E. and G？nnert, R. (1964) Gastropod Combating Salicylanilides. US3147300. |
| [11] | Bekhli, A.F., et al. (1965) Synthesis of Phenasal. Meditsinskaia promyshlennost’SSSR, 19, 25-27. (In Russian) |
| [12] | Florey, K. (2005) Profiles of Drug Substances, Excipients and Related Methodology. Academic Press, Cambridge, Vol. 32, 67-96. |
| [13] | Kar, A. (2004) Advanced Practical Medicinal Chemistry/Theory Methodology Purification Usages. New Age International (P) Ltd., New Delhi, 281. |
| [14] | 陈循军, 尹国强, 崔英德. 氯硝柳胺的合成工艺研究[J]. 精细石油化工进展, 2005, 6(7): 47-49. |
| [15] | Strufe, R., Scluaufst？tter, E. and G？nnert, R. (1963) Alkanolamine Salts of Salicyl Anilides and Process for Their Production. US3113067. |
| [16] | Doan, T.L., et al. (2011) Chap. 23. The Future of Drug Repositioning: Old Drugs, New Opportunities. In: Macor, J.E., Ed., Annual Reports in Medicinal Chemistry (Book Series), Vol. 46, Elsevier Inc., Amsterdam, 385-401.
https://doi.org/10.1016/B978-0-12-386009-5.00004-7 |
| [17] | Thayer, A.M. (2012) Drug Repurposing. Chemical & Engineering News, 90, 15-25.
https://doi.org/10.1021/cen-09040-cover |
| [18] | Chong, C.R. and Sullivan Jr., D.J. (2007) New Uses for Old Drugs. Nature, 448, 645-646.
https://doi.org/10.1038/448645a |
| [19] | Ashburn, T. and Thor, K. (2004) Drug Repositioning: Identifying and Developing New Uses for Existing Drugs. Nature Reviews Drug Discovery, 3, 673-683. https://doi.org/10.1038/nrd1468 |
| [20] | Chisholm, K.M., Chang, K.W., Truong, M.T., Kwok, S., West, R.B. and Heerema-McKenney, A.E. (2012) β-Adrenergic Receptor Expression in Vascular Tumors. Modern Pathology, 25, 1446-1451.
https://doi.org/10.1038/modpathol.2012.108 |
| [21] | Drug Repurposing. https://cdcn.org/repurpose |
| [22] | Barratt, M.J. and Frail, D.E. (2012) Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs. John Wiley & Sons, Hoboken. https://doi.org/10.1002/9781118274408 |
| [23] | Persidis, A. (2015) Myths and Realities of Repositioning. Arrowhead 4th Annual Drug Repositioning, Repurposing & Rescue Conference, Chicago, 27-28 May 2015. |
| [24] | Graul, A.I., Sorbera, L., Pina, P., et al. (2010) The Year’s New Drugs & Biologics—2009. Drug News & Perspectives, 23, 7-36. https://doi.org/10.1358/dnp.2010.23.1.1440373 |
| [25] | BCC Research (2016, January) Global Markets for Drug Repurposing.
https://www.bccresearch.com/market-research/pharmaceuticals/drug-repurposing-markets-report.html |
| [26] | Zhao, K. and So, H.-C. (2019) Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing. In: Methods in Molecular Biology (Book Series), Vol. 1903, Springer, Berlin, 219-237.
https://doi.org/10.1007/978-1-4939-8955-3_13 |
| [27] | Saraswathy, G.R., et al. (2020) Chapter 4. Unveiling Potential Anticancer Drugs through in Silico Drug Repurposing Approaches. In: To, K.K.W. and Cho, W.C.S., Eds., Drug Repurposing in Cancer Therapy: Approaches and Applications, Elsevier Inc., Amsterdam, 81-119. https://doi.org/10.1016/B978-0-12-819668-7.00004-X |
| [28] | Vanhaelen, Q. (2019) Computational Methods for Drug Repurposing. Springer Science, Berlin.
https://doi.org/10.1007/978-1-4939-8955-3 |
| [29] | Jarada, T.N., Rokne, J.G. and Alhajj, R. (2021) SNF-NN: Computational Method to Predict Drug-Disease Interactions Using Similarity Network Fusion and Neural Networks. BMC Bioinformatics, 22, Article No. 28.
https://doi.org/10.1186/s12859-020-03950-3 |
| [30] | Scheffler, B., Glas, M. and Wieland, A. (2017) Niclosamide and Its Derivatives for Use in the Treatment of Solid Tumors. US 9,844,522. |
| [31] | Jourdan, J.-P., Bureau, R., Rochais, C. and Dallemagne, P. (2020) Drug Repositioning: A Brief Overview. Journal of Pharmacy and Pharmacology, 72, 1145-1151. https://doi.org/10.1111/jphp.13273 |
| [32] | 张伦. 阿司匹林国内外的应用、生产和市场[J]. 化工时刊, 1997, 11(4): 29-32. |
| [33] | 数据: 全球每年被吃掉1500亿片阿司匹林为何用量这么大? [EB/OL].
http://www.mnjkw.cn/yaopin/1913181.html, 2018-01-02. |
| [34] | 轩秀晨, 黄卉, 吕桂香. 氯硝柳胺的药理学作用及机制研究进展[J]. 医学综述, 2021, 27(15): 3055-3060. |
| [35] | Chen, W., Mook Jr., R.A., Premont, R.T., et al. (2018) Niclosamide: Beyond an Anthelmintic Drug. Cellular Signalling, 41, 89-96. https://doi.org/10.1016/j.cellsig.2017.04.001 |
| [36] | Niclosamide—A Drug for More than One Purpose.
https://www.niclosamide.org/niclosamide-a-drug-for-more-than-one-purpose |
| [37] | Barbosa, E.J., Lobenberg, R., de Araujo, G.L.B., et al. (2019) Niclosamide Repositioning for Treating Cancer: Challenges and Nano-Based Drug Delivery Opportunities. European Journal of Pharmaceutics and Biopharmaceutics, 141, 58-69. https://doi.org/10.1016/j.ejpb.2019.05.004 |
| [38] | Chan, M.M., Chen, R. and Fong, D. (2018) Targeting Cancer Stem Cells with Dietary Phytochemical—Repositioned Drug Combinations. Cancer Letters, 433, 53-64. https://doi.org/10.1016/j.canlet.2018.06.034 |
| [39] | Li, Y.H., Li, P.K., Roberts, M.J., et al. (2014) Multi-Targeted Therapy of Cancer by Niclosamide: A New Application for an Old Drug. Cancer Letters, 349, 8-14. https://doi.org/10.1016/j.canlet.2014.04.003 |
| [40] | Pantziarka, P., Sukhtame, V., Meheus, L., et al. (2017) Repurposing Non-Cancer Drugs in Oncology—How Many Drugs Are out There? https://doi.org/10.1101/197434 |
| [41] | Braga, L., Ali, H., Secco, I., et al. (2021) Drugs That Inhibit TMEM16 Proteins Block SARS-CoV-2 Spike-Induced Syncytia. Nature, 594, 88-93. https://doi.org/10.1038/s41586-021-03491-6 |
| [42] | Yu, S., Piao, H., Rejinold, N.S., et al. (2021) Niclosamide-Clay Intercalate Coated with Nonionic Polymer for Enhanced Bioavailability toward COVID-19 Treatment. Polymers (Basel), 13, 1044.
https://doi.org/10.3390/polym13071044 |
| [43] | Al-kuraishy, H.M., Al-Gareeb, A.I., Alzahrani, K.J., et al. (2021) Niclosamide for Covid-19: Bridging the Gap. Molecular Biology Reports, 48, 8195-8202. https://doi.org/10.1007/s11033-021-06770-7 |
| [44] | Triggle, D.J. (2006) Comprehensive Medicinal Chemistry II, Vol. 8, Sets. Elsevier, Amsterdam, Vol. 7, 273. |
| [45] | Marrugal-Lorenzo, J.A., Serna-Gallego, A., Berastegui-Cabrera, J., et al. (2019) Repositioning Salicylanilide Anthelmintic Drugs to Treat Adenovirus Infections. Scientific Reports, 9, Article No. 17.
https://www.nature.com/scientificreports
https://doi.org/10.1038/s41598-018-37290-3 |
